Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Cryptospirolepine
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Polydatin
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Shufeng Jiedu
Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020
Gallocatechin gallate
Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020
Ac-QS5-VS
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020
ACE2 receptor trap
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/22/2020
Lupinifolin
Potential treatment - theoretical effect Natural product Antiviral Oct/21/2020
Almitrine
Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/21/2020
Xuanfei Baidu decoction
Potential treatment - clinical evidence Experimental Unknown Oct/21/2020
SATPdb18674
Potential treatment - theoretical effect Experimental Antiviral Oct/21/2020
VH3 B01
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VH2 A01-B01
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
VH2 A01-B02
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020
Tolazamide
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Glyburide
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Zanamivir
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Ganciclovir
Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/20/2020
Peramivir
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
Fosamprenavir
Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020
SARS-CoV-2 HRC lipopeptide
Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020